share_log

《復牌》復宏漢霖(02696.HK)獲復星醫藥(02196.HK)每股24.6元提私有化

Henlius (02696.HK) has been privatized by Fosun Pharma (02196.HK) at a price of 24.6 yuan per share.

AASTOCKS ·  Jun 25 00:04

Fosun Pharma (02196.HK) announced a proposal to privatize Henlius (02696.HK) through absorption and merger, with a cash cancellation price of HKD 24.6 per listed H share, representing a premium of 30.57% to the suspension price before for Henlius. The transaction involves approximately HKD 3.225 billion. Upon completion of the transaction, Henlius will apply for a voluntary delisting of its H shares from the Hong Kong Stock Exchange.

Trading of Henlius shares has resumed on Tuesday (25th).

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment